Home Top Movers What Prompted TENX Stock To Surge 17% In Last Session?

What Prompted TENX Stock To Surge 17% In Last Session?

The stock of Tenax Therapeutics, Inc. (NASDAQ: TENX) closed the previous session at $2.08, meaning its value has risen 307.76% higher than its 52-week low. In intraday trading, Tenax stock hit a low of $2.03 and a high of $2.47.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

A recent trading session has witnessed an intraday change of just 16.85% while TENX stock has had a 52-week high of $3.68 and a low of $0.51. An increase in TENX stock accompanied the positive results of a phase 2 study on its candidate for the treatment of cardiovascular disease.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The TENX study found what?

A specialty pharmaceutical company, Tenax Therapeutics, focuses on identifying and developing products with high unmet medical needs for cardiovascular diseases and pulmonary diseases. TENX facilitates access to world-class scientific advisory teams, which include globally recognized experts in pulmonary hypertension.

Read More

On Friday, Tenax announced that it had published positive results from its Phase 2 HELP study that examined levosimendan’s efficacy in patients with Cardiopulmonary Hypertension associated with Heart Failure.

  • TENX has published a new publication titled Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Placebo-Controlled HELP Trial.
  • This article was published in the Journal of the American College of Cardiology.
  • Through this 6-week study, TENX examined the haemodynamics of individuals who were invasively monitored by their cardiovascular system as well as secondary clinical outcomes such as a 6-minute walk test.
  • According to the TENX study published in the journal, 84% of the participants responded.
  • The primary endpoint of exercise-PCWP was not significantly reduced by levosimendan, compared with placebo, but PCWP was effectively reduced across all phases of exercise.
  • Compared to a control group, 6 MWD experienced a 29.5 meter improvement from the levosimendan treatment.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

TENX’s further plans:

Levosimendan is currently in Phase 2 clinical trials to treat PH-HFpEF and developed by Tenax (TENX), which also has the rights to develop and commercialize this drug. Based on the TENX study’s results, further study of levosimendan in PH-HFpEF patients is warranted since this is the first drug that could demonstrate improved cardiomyopathy and improved six-minute walking distance compared to placebo.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Why Gaotu Techedu Inc. (GOTU) stock went up on Wednesday despite headwinds?

Gaotu Techedu Inc. (GOTU) shares rose 1.38% in after-hours on Wednesday, July 28, 2021, and closed the daily trade at $3.67. Earlier in the...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Antero Resources Corp. (AR) stock fell during after-market. Here’s to know why?

Antero Resources Corp. (NASDAQ: AR) stock plunged by 0.58% at last close while the AR stock price declines by 6.59% in the after-hours trading...

Related News

Why Electrameccanica Vehicles Corp. (SOLO) stock performed well on Wednesday?

Electrameccanica Vehicles Corp. (SOLO) shares gained 5.71% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $3.70 per share. in...

Encore Wire Corporation Inc. (WIRE) stock surges during current market. Here’s to know why?

Encore Wire Corporation Inc. (NASDAQ: WIRE) stock gained by 11.10% in the current market trading session. Encore Wire Corporation is a prominent manufacturer of...

Why Futu Holdings Limited (FUTU) stock is surging in pre-market on Wednesday?

Futu Holdings Limited (FUTU) shares surged 7.56% in pre-market on Wednesday, July 28, 2021, as of this writing. Yesterday in the after-hours session, FUTU's...

Mattel Inc. (MAT) stock surged during pre-market trading, post financial results announcement

Mattel Inc. (NASDAQ: MAT) stock declined by 1.2% at the last close whereas the MAT stock price rises by 5.26% in the pre-market trading...

Here is why Juniper Networks Inc. (JNPR) stock plunged in the after-markets on Tuesday?

Juniper Networks Inc. (JNPR) shares declined 6.01% in after-hours on Tuesday, July 27, 2021, and closed the daily trading at $25.98 per share. in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam